http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120012353-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27943e434a30bbc562b14cdb0a1fdab6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aaa31c6c961512eaff316578bac7701 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 2010-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_824c930cef8010f7705a8d4c30c0d77f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68a8071df109ffb54addbe8c337c2216 |
| publicationDate | 2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120012353-A |
| titleOfInvention | Therapeutic material containing human recombinant bone morphogenetic protein and heparin and manufacturing method thereof |
| abstract | The present invention relates to a therapeutic substance formed by mixing a certain amount of heparin with bone morphogenetic proteins, specifically, osteoinduction and stem cells into osteoblasts. A therapeutic substance containing heparin and bone forming proteins that promote differentiation. In the mixing of the bone morphogenic protein and the heparin, the concentration of the bone morphogenetic protein is 100 ng / mL or more and 10 μg / mL or less, and the concentration of the heparin is 0.01 μg / mL or more and 50 μg / mL or less. You can do |
| priorityDate | 2010-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.